Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fast-growing affiliate company with global focus

The online casino market online is growing rapidly right now around the world. Only in Sweden a new online casino is launched each week and the competition for new players is incredibly tough. In order to attract new players the casinos are forced to either invest heavily in advertising or to offer generous welcome bonuses for new players. Because of the wide range of online casinos on the market comparison sites that drives traffic to the casinos have become increasingly more popular. A very successful comparison site is Casinomir.com and they have the ambition to become the world's leading

Elekta and Varian settle patent litigation

STOCKHOLM, April 3, 2017 – Elekta (EKTA-B.ST) and Varian Medical Systems (NYSE: VAR) have reached a confidential settlement agreement to end ongoing patent litigation involving technology used for radiation oncology and the treatment of cancer. Varian and Elekta resolved the multi-year disputes in the United States, Germany, and the United Kingdom, including the suit brought by Elekta AB and William Beaumont Hospital, with no payments exchanged by the plaintiffs and defendants and no future financial obligations. The two companies have been in litigation since 2015. # # # For further

Norwegian competition authority approves Telia Company’s acquisition of Phonero

The Norwegian competition authority has today approved Telia Company’s acquisition of Phonero. The transaction will strengthen Telia’s position in the Norwegian enterprise segment.“I’m very happy to see that we are making good progress in Norway which is a market where I see a great potential for Telia Company to invest more and give more to our customers and society. The acquisition of Phonero will strengthen our position and make us an even stronger challenger in the enterprise segment,” says Johan Dennelind, President and CEO Telia Company.      Telia has in record time made

AniCura significantly expands its veterinary offering in the Netherlands with the acquisition of Sterkliniek Dierenartsen

AniCura, one of Europe’s leading providers of high-quality veterinary care for companion animals, acquires Sterkliniek Dierenartsen BV, a nationwide veterinary group comprising 82 veterinary clinics well-known for their quality focus. The acquisition strengthens AniCura's position as the leading provider of veterinary care in the Netherlands.AniCura was founded in 2011 as the first merger of animal hospitals in Sweden. Following its inception, the company has grown rapidly to currently comprise 150 animal hospitals and veterinary clinics throughout Europe. AniCura entered the Dutch market

Ossur Hf : Transactions in relation to share buyback program

Announcement from Össur hf. No. 27/2017Reykjavík, 3 April 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 30 November 2017. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The total consideration

Eniro presents recapitalization plan

Translation of Swedish press release distributed April 3, 2017, 07.45 CET  · Offering to holders of convertibles and preference shares to exchange convertibles to ordinary shares · New issue of ordinary shares for SEK 275 M · Decrease in interest-bearing loans by SEK 828 M if owners of convertibles and preference shares accept the offer and the new issue of ordinary shares of SEK 275 M is carried outStockholm Nasdaq-listed Eniro AB (publ) (“Eniro” or “the Company”)[1] 

United Bankers Oyj: SHARE REPURCHASE 3.4.2017

United Bankers Oyj     STOCK EXCHANGE ANNOUNCEMENT     3.4.2017 SHARE REPURCHASE 3.4.2017 In the Helsinki Stock Exchange Trade date 3.4.2017Bourse trade BUYShare UNIAVAmount 25 sharesAverage price/ share 34.6500 EURTotal cost 866,25 EUR United bankers Oyj now holds a total of 8 193 sharesincluding the shares repurchased on 3.4.2017. On behalf of United Bankers Oyj Nordea Bank AB (publ), Finnish BranchJanne Sarvikivi         Julius Summanen

DiviTum® results in blockbuster drug study presented at AACR

Uppsala, Sweden, April 3 2017. The latest data of the DiviTum® assay as an efficacy marker of CDK4/6 inhibition was presented in an oral session by Dr. Geoffrey Shapiro, Dana-Farber Cancer Institute, at the 2017 American Association for Cancer Research (AACR) Annual Meeting.The results, presented as part of an ongoing clinical trial (NCT02022982) at the Dana-Farber Cancer Institute, demonstrate that the DiviTum® assay for determining Thymidine Kinase Activity (TKA) can be a practical, non-invasive tool for monitoring the efficacy of CDK4/6 inhibitors. There is a great need for a method that

Exchange rates for the first quarter of 2017

The net foreign exchange impact of the Kindred Group’s main trading currencies against its reporting currency of GBP is shown in the tables below. While this has no material impact on the underlying development in Kindred Group’s business, it does affect the reported results when translated into GBP. The weighted average impact of GBP against Kindred Group’s main currencies was a positive impact on Gross winnings revenue of approximately 10-11 per cent in the first quarter of 2017 compared to the same period of 2016.Balancesheetrates:Rate to 31-Mar-16 31-Mar-17

UTA assistant professor awarded American Physical Society’s Mitsuyoshi Tanaka Dissertation Award in Experimental Particle Physics

The American Physical Society has awarded Benjamin Jones, assistant professor of Physics at The University of Texas at Arlington, the Mitsuyoshi Tanaka Dissertation Award in Experimental Particle Physics, which is widely considered the most prestigious dissertation award in the field. Jones received the award for his doctoral thesis from Massachusetts Institute of Technology, “Sterile Neutrinos in Cold Climates,” which was based on his research on the IceCube experiment at the South Pole. IceCube is an international collaboration of scientists from 48 institutions in 12 countries,

Orkla ASA: Mandatory notification of trade - options

On 3 April, in connection with Orkla's former management option programme, 25,000 options in Orkla-shares were exercised at a strike price of NOK 40.03 per share.After this transaction, the total number of options issued in Orkla shares under the management option programme is 575,000. Orkla owns 2,333,135 treasury shares.Orkla ASAOslo, 3 April 2017Ref.:Investor RelationsElise HeidenreichTel.: +47 951 41 147   This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Notice of Annual General Meeting 2017 of AB Fagerhult (publ)

Shareholders of AB Fagerhult (publ), Corporate Identity Number 556110-6203, are hereby given notice of the Annual General Meeting of the Company to be held on Wednesday, 3 May 2017 at 5:00 p.m. in Fagerhult, Åvägen 1, SE-566 80, Habo, Sweden.A.     REGISTRATION Shareholders wishing to take part in the Annual General Meeting (AGM) must be registered in the shareholders’ register kept by Euroclear Sweden AB no later than Wednesday, 26 April 2017 and register their attendance with Fagerhult no later than 26 April 2017. Registration can be done by e-mail at arsstamma@fagerhult.se, by

Total Voting Rights

3 April 2017 15:00 BST Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1.  As at 31 March 2017 the issued share capital of AstraZeneca PLC with voting rights is 1,265,602,163 ordinary shares of US$0.25.  No shares are held in Treasury.  Therefore, the total number of voting rights in AstraZeneca PLC is 1,265,602,163. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they

Ahlstrom-Munksjö Oyj: Change in the holding of Ilmarinen Mutual Pension Insurance Company

AHLSTROM-MUNKSJÖ OYJ, STOCK EXCHANGE RELEASE April 3, 2017 at 16:15 CESTHelsinki, Finland  Ahlstrom-Munksjö Oyj: Change in the holding of Ilmarinen Mutual Pension Insurance Company Ahlstrom-Munksjö Oyj (“Ahlstrom-Munksjö”) has today received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Ilmarinen Mutual Pension Insurance Company. The announcement includes the following information: The holding of Ilmarinen in Ahlstrom-Munksjö has fallen below the 5% threshold as a consequence of the merger of Ahlstrom Corporation into Munksjö

Ahlstrom-Munksjö Oyj: Change in the holdings of AC Invest Five BV and AC Invest Six BV

AHLSTROM-MUNKSJÖ OYJ, STOCK EXCHANGE RELEASE 3 April 2017 at 16:15 CESTHelsinki, Finland Ahlstrom-Munksjö Oyj: Change in the holdings of AC Invest Five BV and AC Invest Six BV Ahlstrom-Munksjö Oyj (“Ahlstrom-Munksjö”) has today received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Ahlström Capital Oy on behalf of AC Invest Five BV and AC Invest Six BV. According to the notification, as a consequence of the merger of Ahlstrom Corporation into Munksjö Oyj, the proportion of Ahlstrom-Munksjö shares owned by AC Invest Five BV, a

SCA’s acquisition of BSN medical now closed

SCA’s acquisition of BSN medical, a leading medical solutions company, has been closed. The company develops, manufactures, markets and sells products within wound care, compression therapy and orthopedics. The purchase price for the shares amounts to EUR 1,400m and takeover of net debt to approximately EUR 1,340m1). SCA consolidates BSN medical as of April 3, 2017.BSN medical’s sales for 2016 amounted to EUR 850m (SEK 8,038m) and adjusted EBITDA2) for 2016 was EUR 210m (SEK 1,986m). Organic sales, which excludes exchange rate effects, acquisitions and divestments, increased by 5.3%. BSN

Swedish pine is a material of the future in China, according to a trend report

Wood products in Swedish pine were exhibited in the China Design Trends Gallery at Asia’s leading international design event, Design Shanghai, on 8-11 March 2017. The pine was used to illustrate the trend “Playful Craftsmanship”, which reflects the demand from the Chinese middle class for unique design that tells a story.The Chinese middle class and the wealthy younger generation, well-educated and with unique personal tastes, are focusing more and more on consumer experiences and the story behind the products they buy. And they are willing to pay extra for products that reflect their

Repeat Order from South Korean Customer

Asetek today announced a second order from Intech, Seoul, South Korea, for its InRackCDU D2C™ (Direct-to-Chip) liquid cooling solution. The order is for validation by an undisclosed customer of Intech. “The magnitude of this order lies in its strategic significance. It marks yet another step towards unlocking the full potential our partnership with Intech, through validation of our product by one of their customers and increasing end-user adoption of our technology,” said André Sloth Eriksen, CEO and founder of Asetek. The order will result in revenue to Asetek in the range of USD 25,

Trading statistics, March 2017

In March, 2,309,799 trades were made in stocks, warrants and options among Nordnet’s customers in Sweden, Norway, Denmark and Finland. That corresponds to 100,426 trades on average per day. The total number of transactions is the highest ever for Nordnet, but since the number of trading days in March was 23, the number of trades per trading day is lower than in January and February.- We saw quite small movements in the Nordic markets for March as a whole, says Håkan Nyberg, CEO of Nordnet. The first reporting period is over and the private savers are now waiting for the Q1 reports that come

Notice of Annual General Meeting

The shareholders of Lifco AB (publ) are hereby invited to attend the Annual General Meeting (AGM) to be held on Thursday 4 May 2017, at 3 p.m. CET at Bonnierhuset, Torsgatan 21 in Stockholm, Sweden. Right to attend Shareholders who wish to attend the AGM must: -        be recorded in the register of shareholders maintained by Euroclear Sweden AB (the Swedish Central Securities Depository) on Thursday 27 April 2017, and -        notify the Company of their intention to participate in the meeting not later than on Thursday 27 April 2017. Shareholders who have trustee-registered

Episurf Medical AB to present at Aktiespararna’s Börskväll, held in Stockholm on April 20

Episurf Medical AB will present at Aktiespararna’s Börskväll, an investor conference held in Stockholm (Hotel Rival) on April 20. The event is arranged by Aktiespararna and the company will be represented by acting CEO Pål Ryfors. For full program and registration, see link. The presentation will be available on the company’s website. For more information, please contact: Pål Ryfors, acting CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring

Episurf Medical’s 50th Episealer® implant in Germany demonstrates rapid clinical adoption

Episurf Medical announces that the 50th implantation in Germany of the Episealer® knee implant will take place in the coming days. Episurf Medical intensified its activities in Germany during 2016 and the company’s technology has been very well received by key surgeons in the country. Germany is one of the company's prioritized markets. “In Germany we started our efforts in the regions around Berlin, Hamburg and Münster with great results. We then continued to focus on additional German regions and have today a sales team covering all parts of Germany. The clinical feedback from surgeons

There are no items matching the current filter
There are no more items matching the current filter
Back to top